enews
November 2021 Old Cancer Drug May Have New Purpose: Treating Chronic Pain Over the years, several drugs that were developed to treat medical conditions such as epilepsy and depression have been repurposed as treatments for chronic pain. Pregabalin (Lyrica) and duloxetine (Cymbalta) are just two examples. Another drug that used to be used …
October 2021 A Comprehensive Guide to the Top Pain-Relieving Devices on the Market Managing chronic pain takes work. Between appointments with your doctor, pain specialist, physical therapist, acupuncturist, and massage therapist, there are medications to keep up with, diet, exercise, and stress-reduction routines to follow – we know that the struggle is …
September 2021 Why Losing Weight is Good for Brain Health Having too much body fat can threaten brain health in multiple ways: It can increase the odds of developing high blood pressure, type 2 diabetes, and unhealthy blood fats. Moreover, a study by FPN’s Scientific Advisor, Eva Feldman, MD, PhD, FAAN, published in the Journal …
August 2021 PN Awareness Video: Please share! During Peripheral Neuropathy Awareness Week, FPN put out a call for videos answering the question: “What Do You Wish People Knew About Peripheral Neuropathy?” Our incredible volunteer, Diva, pulled your answers together into a new and fantastic awareness video on peripheral neuropathy. Take a look at …
July 2021 One Step Closer The research study on Anti-MAG peripheral neuropathy is progressing nicely, with more sites and patients participating throughout the world. FPN is pleased to play an integral role in supporting these research efforts for physicians and patients affected by this rare form of PN. Learn more. …
June 2021 FPN Welcomes Kristy Townsend We are pleased to announce a new member of the FPN Board of Directors, effective June 1. Kristy Townsend, PhD in Neuroscience, brings a wealth of information in peripheral neuropathy research, and we are lucky to have her on our team. Read more. Hypothyroidism and PN Hypothyroidism …
May 2021 New Research Study Underway using FPN’s Biobank, the PNRR The Scripps Research Institute, in collaboration with Protego Biopharma and the Kelly Laboratory, have gained access to plasma samples from the Peripheral Neuropathy Research Registry (PNRR) for a unique research study on the biochemical mechanisms of amyloid diseases. This study will use …
April 2021 Peripheral Neuropathy and Mental Health Mental health can become a concern for patients with chronic conditions such as peripheral neuropathy. During recent months when the pandemic has disrupted many of our usual routines, mental health for patients and their families can become even more of an issue. The Foundation for Peripheral Neuropathy asked two experts …
March 2021 NeuroCOVID DataBank A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions. The COVID-19 Neuro Databank/Biobank, dubbed “NeuroCOVID,” was created by the National Institutes of Health (NIH) and will be maintained by NYU Langone Health. Learn more. …
February 2021 More Action for PN Research Last year’s advocacy success for peripheral neuropathy must continue. Contact the office of your members of Congress again this year and ask that they support “Peripheral Neuropathy” as a condition eligible for study through the Department of Defense Peer-Reviewed Medical Research Program during the Fiscal Year …
